BioCryst 制药 BCRX
$7.69 +$0.06 (+0.79%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.71 +0.26%
开盘$7.81
昨收$7.63
当日区间$7.38 – $7.83
成交量5.21M
市值$1.98B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$218.25M+33.6% YoY
营业利润$98.47M+230.6% YoY
净利润$78.40M+1,441.7% YoY
摊薄每股收益$0.30+1,400.0% YoY
自由现金流$104.13M+153.2% YoY
经营现金流$104.34M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率97.8%
营业利润率-33.3%
净利率-40.9%
资产收益率-75.8%
流动比率2.32
负债/资产比率181.4%
现金及投资$352.57M
总负债$789.83M
净现金（净负债）-$437.26M
自由现金流/营收39.7%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $218.25M | $156.41M | $874.84M | $406.56M | $159.40M |
| 营业总收入 | $218.25M | $156.41M | $874.84M | $406.56M | $159.40M |
| 营业成本 | $3.84M | $5.38M | $19.08M | $9.52M | $2.19M |
| 毛利润 | $214.41M | $151.04M | $855.76M | $397.03M | $157.21M |
| 营业费用 | $115.95M | $852.63M | $514.77M | $136.65M | $127.62M |
| 销售及管理费用 | $63.98M | $94.55M | $348.65M | $95.78M | $83.01M |
| 研发费用 | $51.97M | $758.08M | $166.13M | $40.87M | $44.60M |
| 营业利润 | $98.47M | -$701.60M | $340.99M | $260.39M | $29.59M |
| 非经营性利息净收入（支出） | -$19.28M | -$17.52M | -$68.20M | -$11.25M | -$17.42M |
| 非经营性利息收入 | $2.43M | $2.26M | $10.67M | $2.89M | $2.24M |
| 非经营性利息支出 | $21.71M | $19.78M | $78.87M | $14.14M | $19.66M |
| 其他收入（支出） | $287,000.00 | -$1.69M | -$5.39M | -$1.12M | -$38,000.00 |
| 证券出售收益 | $27,000.00 | -$225,000.00 | -$152,000.00 | -$125,000.00 | $35,000.00 |
| 特殊收益（费用） | $0.00 | – | -$17.33M | -$10.42M | -$2.74M |
| 其他非经营性收入（支出） | $260,000.00 | -$1.46M | $12.09M | $9.42M | $2.67M |
| 税前利润 | $79.47M | -$720.81M | $267.39M | $248.02M | $12.13M |
| 税费 | $1.08M | $1.00M | $3.53M | $2.17M | -$769,000.00 |
| 净利润 | $78.40M | -$721.81M | $263.86M | $245.85M | $12.90M |
| 持续经营利润 | $78.40M | -$721.81M | $263.86M | $245.85M | $12.90M |
| 归属母公司净利润 | $78.40M | -$721.81M | $263.86M | $245.85M | $12.90M |
| 归属普通股股东净利润 | $78.40M | -$721.81M | $263.86M | $245.85M | $12.90M |
| 基本每股收益 | $0.31 | -$2.98 | $1.26 | $1.17 | $0.06 |
| 摊薄每股收益 | $0.30 | -$2.98 | $1.21 | $1.12 | $0.06 |
| -减：其他特殊支出 | – | – | $17.33M | $10.42M | $2.74M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $557.85M | $465.05M | $514.16M | $514.16M | $446.42M |
| 流动资产合计 | $484.68M | $373.63M | $404.35M | $404.35M | $355.68M |
| 现金及现金等价物与短期投资 | $352.57M | $238.40M | $274.75M | $274.75M | $212.87M |
| -现金及现金等价物 | $154.97M | $171.59M | $89.74M | $89.74M | $84.08M |
| -短期投资 | $197.60M | $66.81M | $185.01M | $185.01M | $128.80M |
| 应收款 | $110.76M | $109.27M | $106.82M | $106.82M | $91.33M |
| -应收账款 | $110.76M | $109.27M | $106.82M | $106.82M | $91.33M |
| 存货 | $6.06M | $5.99M | $5.40M | $5.40M | $5.23M |
| 受限现金 | $479,000.00 | $854,000.00 | $201,000.00 | $201,000.00 | $579,000.00 |
| 其他流动资产 | $14.82M | $19.11M | $17.18M | $17.18M | $16.50M |
| 非流动资产合计 | $73.17M | $91.43M | $109.81M | $109.81M | $90.74M |
| 固定资产净值 | $21.67M | $22.99M | $18.99M | $18.99M | $19.24M |
| -固定资产原值 | $21.67M | $22.99M | $28.38M | $28.38M | $19.24M |
| 投资及预付款 | $0.00 | $20.57M | $61.16M | $61.16M | $39.67M |
| 其他非流动资产 | $51.50M | $47.87M | $29.66M | $29.66M | $31.84M |
| 负债合计 | $1.01B | $1.02B | $633.31M | $633.31M | $834.31M |
| 流动负债合计 | $208.85M | $195.39M | $196.07M | $196.07M | $190.24M |
| 应付款 | $11.46M | $10.96M | $24.79M | $24.79M | $5.57M |
| -应付账款 | $11.46M | $10.96M | $15.83M | $15.83M | $5.57M |
| 一年内应计费用 | $121.90M | $119.40M | $39.96M | $39.96M | $118.78M |
| 短期债务及融资租赁负债 | $3.00M | $3.09M | $1.63M | $1.63M | $1.78M |
| -一年内到期融资租赁负债 | $3.00M | $3.09M | $1.63M | $1.63M | $1.78M |
| 一年内递延负债 | $12.32M | $5.41M | – | – | – |
| 其他流动负债 | $60.17M | $56.53M | $52.20M | $52.20M | $64.11M |
| 非流动负债合计 | $803.29M | $823.50M | $437.25M | $437.25M | $644.08M |
| 长期债务及融资租赁负债 | $789.83M | $814.67M | $437.25M | $437.25M | $643.64M |
| -长期债务 | $778.38M | $802.38M | $427.23M | $427.23M | $633.47M |
| -长期融资租赁负债 | $11.45M | $12.30M | $10.01M | $10.01M | $10.17M |
| 一年以上递延负债 | $13.46M | $8.83M | – | – | – |
| 股东权益合计 | -$454.29M | -$553.84M | -$119.15M | -$119.15M | -$387.89M |
| 股东权益 | -$454.29M | -$553.84M | -$119.15M | -$119.15M | -$387.89M |
| 股本 | $2.55M | $2.54M | $2.13M | $2.13M | $2.11M |
| -普通股 | $2.55M | $2.54M | $2.13M | $2.13M | $2.11M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.69B | $1.67B | $1.38B | $1.38B | $1.36B |
| 留存收益 | -$2.15B | -$2.23B | -$1.51B | -$1.51B | -$1.75B |
| 不影响留存收益的损益 | -$528,000.00 | -$368,000.00 | $38,000.00 | $38,000.00 | $1.14M |
| -累计折旧 | – | – | -$9.39M | -$9.39M | – |
| -其他应付款 | – | – | $8.96M | $8.96M | – |
| 一年内预提费用 | – | – | $26.63M | $26.63M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $104.34M | -$61.79M | $347.37M | $291.96M | $41.62M |
| 持续经营经营活动现金流净额 | $104.34M | -$61.79M | $347.37M | $291.96M | $41.62M |
| 持续经营净利润 | $78.40M | -$721.81M | $263.86M | $245.85M | $12.90M |
| 持续经营损益 | $524,000.00 | $2.81M | $26.45M | $20.09M | $2.19M |
| 折旧、折耗与摊销 | $513,000.00 | $461,000.00 | $1.39M | $394,000.00 | $335,000.00 |
| 其他非现金项目 | $13.75M | $711.88M | $30.85M | -$1.23M | $3.13M |
| 营运资金变动 | -$3.11M | -$71.40M | -$56.90M | $4.23M | -$1.37M |
| -应收款变动 | -$1.49M | -$474,000.00 | -$36.81M | -$15.49M | -$17,000.00 |
| -存货变动 | -$4.35M | -$4.85M | -$1.64M | -$515,000.00 | -$1.69M |
| -预付资产变动 | $4.43M | $3.53M | -$7.83M | -$1.94M | -$5.92M |
| -应付账款及应计费用变动 | $5.07M | -$60.40M | $57.80M | $35.36M | $24.58M |
| -其他流动负债变动 | -$18.32M | -$8.47M | -$68.43M | -$13.19M | -$18.32M |
| -其他营运资金变动 | $11.54M | -$749,000.00 | – | – | – |
| 投资活动现金流净额 | -$110.15M | -$268.65M | -$13.69M | -$83.49M | $13.57M |
| 持续经营投资活动现金流净额 | -$110.15M | -$268.65M | -$13.69M | -$83.49M | $13.57M |
| 固定资产购置及出售净额 | -$209,000.00 | -$403,000.00 | -$2.47M | -$802,000.00 | -$1.34M |
| 业务购买及出售净额 | $0.00 | -$489.48M | -$6.18M | – | – |
| 投资购置及出售净额 | -$109.94M | $221.24M | -$5.59M | -$76.50M | $14.37M |
| 筹资活动现金流 | -$11.15M | $412.55M | -$349.93M | -$217.96M | -$58.81M |
| 持续经营筹资活动现金流净额 | -$11.15M | $412.55M | -$349.93M | -$217.96M | -$58.81M |
| 债务发行及偿还净额 | -$361,000.00 | $399.66M | -$301.99M | -$184.58M | -$46.85M |
| 普通股发行净额 | $44,000.00 | $33,000.00 | $59,000.00 | $23,000.00 | $21,000.00 |
| 股票期权行使所得 | $6.20M | $19.48M | $9.12M | $657,000.00 | $2.65M |
| 其他筹资费用净额 | -$17.04M | -$6.62M | -$57.12M | -$34.06M | -$14.63M |
| 期末现金余额 | $156.38M | $173.38M | $91.34M | $91.34M | $86.06M |
| 现金净变动 | -$16.96M | $82.11M | -$16.26M | -$9.49M | -$3.62M |
| 期初现金余额 | $173.38M | $91.34M | $106.32M | $86.06M | $89.93M |
| 汇率变动影响 | -$35,000.00 | -$72,000.00 | $1.27M | -$72,000.00 | -$468,000.00 |
| 自由现金流 | $104.13M | -$62.19M | $344.90M | $291.16M | $40.28M |
| 其他投资变动净额 | – | – | $550,000.00 | $0.00 | – |
暂无评论——快来第一个聊聊 BCRX。
登录后参与讨论。